<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://drugfacts.org.uk/index.php?action=history&amp;feed=atom&amp;title=Mirtazapine</id>
	<title>Mirtazapine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://drugfacts.org.uk/index.php?action=history&amp;feed=atom&amp;title=Mirtazapine"/>
	<link rel="alternate" type="text/html" href="https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;action=history"/>
	<updated>2026-04-24T13:28:27Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.31.1</generator>
	<entry>
		<id>https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=558&amp;oldid=prev</id>
		<title>Sharon: /* Classification */</title>
		<link rel="alternate" type="text/html" href="https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=558&amp;oldid=prev"/>
		<updated>2017-05-06T14:38:40Z</updated>

		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Classification&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:38, 6 May 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot; &gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antidepressant, hallucinogen&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antidepressant, hallucinogen&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Antidepressant&lt;/del&gt;]][[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Hallucinogenic&lt;/del&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Antidepressants&lt;/ins&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Hallucinogenics&lt;/ins&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Overview ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Overview ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Sharon</name></author>
		
	</entry>
	<entry>
		<id>https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=557&amp;oldid=prev</id>
		<title>Sharon: /* Classification */</title>
		<link rel="alternate" type="text/html" href="https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=557&amp;oldid=prev"/>
		<updated>2017-05-06T14:36:10Z</updated>

		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Classification&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 14:36, 6 May 2017&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l6&quot; &gt;Line 6:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antidepressant, hallucinogen&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Antidepressant, hallucinogen&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Antidepressant]][[Category:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Hallucinogen&lt;/del&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Category:Antidepressant]][[Category:&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Hallucinogenic&lt;/ins&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Overview ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Overview ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Sharon</name></author>
		
	</entry>
	<entry>
		<id>https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=556&amp;oldid=prev</id>
		<title>Sharon: Created page with &quot;== Also known as ==  Remeron, Remeron SolTab, avanza, zispin, axit, mirtaz, mirtazon  == Classification ==  Antidepressant, hallucinogen Category:AntidepressantCategory:...&quot;</title>
		<link rel="alternate" type="text/html" href="https://drugfacts.org.uk/index.php?title=Mirtazapine&amp;diff=556&amp;oldid=prev"/>
		<updated>2017-05-06T14:34:37Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Also known as ==  Remeron, Remeron SolTab, avanza, zispin, axit, mirtaz, mirtazon  == Classification ==  Antidepressant, hallucinogen &lt;a href=&quot;/index.php?title=Category:Antidepressant&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;Category:Antidepressant (page does not exist)&quot;&gt;Category:Antidepressant&lt;/a&gt;Category:...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Also known as ==&lt;br /&gt;
&lt;br /&gt;
Remeron, Remeron SolTab, avanza, zispin, axit, mirtaz, mirtazon&lt;br /&gt;
&lt;br /&gt;
== Classification ==&lt;br /&gt;
&lt;br /&gt;
Antidepressant, hallucinogen&lt;br /&gt;
[[Category:Antidepressant]][[Category:Hallucinogen]]&lt;br /&gt;
&lt;br /&gt;
== Overview ==&lt;br /&gt;
&lt;br /&gt;
Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of moderate to severe depression. Mirtazapine has a tetracyclic chemical structure and is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). It is the only tetracyclic antidepressant that has been approved by the [[FDA]] to treat depression &amp;lt;ref name=&amp;quot;1069a&amp;quot;&amp;gt;'''Mirtazapine''', 2017, https://www.drugbank.ca/drugs/DB00370&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== Medical usage ==&lt;br /&gt;
&lt;br /&gt;
Used to treat depression &amp;lt;ref name=&amp;quot;1068a&amp;quot;&amp;gt;'''Mirtazapine''', 2017, https://www.drugs.com/mirtazapine.html&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== What does it look like? ==&lt;br /&gt;
&lt;br /&gt;
Tablets&lt;br /&gt;
&lt;br /&gt;
== Dosage ==&lt;br /&gt;
&lt;br /&gt;
=== Therapeutic ===&lt;br /&gt;
&lt;br /&gt;
* For oral dosage forms (orally disintegrating tablets, tablets) -&lt;br /&gt;
** For depression -&lt;br /&gt;
*** Adults - at first, 15 milligrams once a day, preferably in the evening just before sleep. Your doctor may adjust your dose if needed. However, the dose is usually not more than 45 mg per day &amp;lt;ref name=&amp;quot;1068a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Abuse ===&lt;br /&gt;
&lt;br /&gt;
==== Oral ====&lt;br /&gt;
&lt;br /&gt;
* threshold	50 - 70 mg,&lt;br /&gt;
* light	80 - 130 mg,&lt;br /&gt;
* common	140 - 90 mg,&lt;br /&gt;
* strong	190 - 240 mg,&lt;br /&gt;
* heavy	250 mg + &amp;lt;ref name=&amp;quot;1067a&amp;quot;&amp;gt;'''Mirtazapine''', 2017, https://psychonautwiki.org/wiki/Mirtazapine&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== What are the different forms? ==&lt;br /&gt;
&lt;br /&gt;
Mirtazapine is available as regular and oral disintegrating tablets of 15, 30 and 45 mg in multiple generic forms and under the brand name Remeron &amp;lt;ref name=&amp;quot;1071a&amp;quot;&amp;gt;'''Mirtazapine''', 2017, https://livertox.nlm.nih.gov//Mirtazapine.htm&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== How long do its effects last? ==&lt;br /&gt;
&lt;br /&gt;
=== Onset of effects ===&lt;br /&gt;
&lt;br /&gt;
15 - 30 minutes &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Peak ===&lt;br /&gt;
&lt;br /&gt;
90 - 180 minutes &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Offset ===&lt;br /&gt;
&lt;br /&gt;
2 - 6 hours &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== After-effects ===&lt;br /&gt;
&lt;br /&gt;
Up to 12 hours &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
&lt;br /&gt;
=== Pharmacodynamics ===&lt;br /&gt;
&lt;br /&gt;
Mirtazapine, an antidepressant of the piperazinoazepine class, is a tetracyclic compound with an [[anxiolytic]] effect. Mirtazapine has fewer ADRs than tricyclic antidepressants and is better tolerated. Selective blockade of specific serotonin receptors by mirtazapine likey minimises side-effects typical of other antidepressants &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Absorption ===&lt;br /&gt;
&lt;br /&gt;
Rapid and complete, but, due to first-pass metabolism, absolute bioavailability is 50% &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Bioavailability ===&lt;br /&gt;
&lt;br /&gt;
50% &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Metabolism ===&lt;br /&gt;
&lt;br /&gt;
Mirtazapine is extensively metabolised by demethylation and hydroxylation followed by glucuronide conjugation. Cytochrome P450 2D6 and cytochrome P450 1A2 are involved in formation of the 8-hydroxy metabolite of mirtazapine, and cytochrome P450 3A4 is responsible for the formation of the N-desmethyl and N-oxide metabolites. Several metabolites possess pharmacological activity, but plasma levels are very low &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Half-life ===&lt;br /&gt;
&lt;br /&gt;
20 - 40 hours &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Elimination ===&lt;br /&gt;
&lt;br /&gt;
This drug is known to be substantially excreted by the kidney (75%) &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;. Urine 75% and faeces 15% &amp;lt;ref name=&amp;quot;1070a&amp;quot;&amp;gt;'''Mirtazapine''', 2017, https://en.wikipedia.org/wiki/Mirtazapine&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Lethal dosage ===&lt;br /&gt;
&lt;br /&gt;
[[LD50]] is 600 - 720mg/kg (oral, mice) and 320 - 490mg/kg (oral, rat) &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Tolerance ===&lt;br /&gt;
&lt;br /&gt;
Tolerance to the effects of mirtazapine are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). Mirtazapine presents cross-tolerance with all psychedelics, meaning that after the consumption of mirtazapine all psychedelics will have a reduced effect &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Mechanism of action ===&lt;br /&gt;
&lt;br /&gt;
Mirtazapine acts as an antagonist at central pre-synaptic alpha(2)-receptors, inhibiting negative feedback to the presynaptic nerve and causing an increase in NE release. Blockade of heteroreceptors, alpha(2)-receptors contained in serotenergic neurons, enhances the release of 5-HT, increasing the interactions between 5-HT and 5-HT1 receptors and contributing to the anxiolytic effects of mirtazapine. Mirtazapine also acts as a weak antagonist at 5-HT1 receptors and as a potent antagonist at 5-HT2 (particularly subtypes 2A and 2C) and 5-HT3 receptors. Blockade of these receptors may explain the lower incidence of adverse effects such as anxiety, insomnia, and nausea. Mirtazapine also exhibits significant antagonism at H1-receptors, resulting in sedation. Mirtazapine has no effects on the reuptake of either NE or 5-HT and has only minimal activity at dopaminergic and muscarinic receptors &amp;lt;ref name=&amp;quot;1069a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== Effects ==&lt;br /&gt;
&lt;br /&gt;
=== Physical effects ===&lt;br /&gt;
&lt;br /&gt;
* changes in gravity,&lt;br /&gt;
* spontaneous tactile sensations,&lt;br /&gt;
* tactile hallucinations,&lt;br /&gt;
* appetite enhancement,&lt;br /&gt;
* motor control loss,&lt;br /&gt;
* sedation,&lt;br /&gt;
* constipation,&lt;br /&gt;
* dizziness &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Cognitive effects ===&lt;br /&gt;
&lt;br /&gt;
* conceptual thinking,&lt;br /&gt;
* time distortion,&lt;br /&gt;
* dream potentiation,&lt;br /&gt;
* immersion enhancement,&lt;br /&gt;
* increased music appreciation,&lt;br /&gt;
* amnesia,&lt;br /&gt;
* information processing suppression,&lt;br /&gt;
* thought deceleration &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Auditory effects ===&lt;br /&gt;
&lt;br /&gt;
* auditory distortion,&lt;br /&gt;
* auditory enhancement,&lt;br /&gt;
* auditory hallucinations &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Visual effects ===&lt;br /&gt;
&lt;br /&gt;
* tracers,&lt;br /&gt;
* geometry,&lt;br /&gt;
* autonomous entities,&lt;br /&gt;
* external hallucinations,&lt;br /&gt;
* internal hallucinations,&lt;br /&gt;
* perspective alterations,&lt;br /&gt;
* scenarios and plots,&lt;br /&gt;
* settings, sceneries, and landscapes &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Minor effects ===&lt;br /&gt;
&lt;br /&gt;
==== More common ====&lt;br /&gt;
&lt;br /&gt;
* constipation,&lt;br /&gt;
* dizziness,&lt;br /&gt;
* drowsiness,&lt;br /&gt;
* dry mouth,&lt;br /&gt;
* increased appetite,&lt;br /&gt;
* weight gain &amp;lt;ref name=&amp;quot;1068a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==== Less common ====&lt;br /&gt;
&lt;br /&gt;
* abdominal or stomach pain,&lt;br /&gt;
* abnormal dreams,&lt;br /&gt;
* back pain,&lt;br /&gt;
* dizziness or fainting when getting up suddenly from a lying or sitting position,&lt;br /&gt;
* increased need to urinate,&lt;br /&gt;
* increased sensitivity to touch,&lt;br /&gt;
* increased thirst,&lt;br /&gt;
* low blood pressure,&lt;br /&gt;
* muscle pain,&lt;br /&gt;
* nausea,&lt;br /&gt;
* sense of constant movement of self or surroundings,&lt;br /&gt;
* trembling or shaking,&lt;br /&gt;
* vomiting,&lt;br /&gt;
* weakness &amp;lt;ref name=&amp;quot;1068a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Major effects ===&lt;br /&gt;
&lt;br /&gt;
==== Less common ====&lt;br /&gt;
&lt;br /&gt;
* decreased or increased movement,&lt;br /&gt;
* mood or mental changes, including abnormal thinking, agitation, anxiety, confusion, and feelings of not caring,&lt;br /&gt;
* shortness of breath,&lt;br /&gt;
* skin rash,&lt;br /&gt;
* swelling &amp;lt;ref name=&amp;quot;1068a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==== Rare ====&lt;br /&gt;
&lt;br /&gt;
* change in menstrual cycle,&lt;br /&gt;
* convulsions,&lt;br /&gt;
* decreased sexual ability,&lt;br /&gt;
* menstrual pain,&lt;br /&gt;
* mood or mental changes, including anger, feelings of being outside the body, [[hallucinations]], mood swings, and unusual excitement,&lt;br /&gt;
* mouth sores,&lt;br /&gt;
* sore throat, chills, or fever &amp;lt;ref name=&amp;quot;1068a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
== History ==&lt;br /&gt;
&lt;br /&gt;
Originally introduced by Organon International in the United States in 1990. Its patent expired in 2004 and hence generic versions are now available &amp;lt;ref name=&amp;quot;1067a&amp;quot;/&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
== References ==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;span id=&amp;quot;BackToTop&amp;quot;&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;noprint&amp;quot; style=&amp;quot;background-color:#fc3; color:#d33; position:fixed; bottom:2%; left:0.25%; padding:0; margin:0;&amp;quot;&amp;gt;&lt;br /&gt;
[[#top| '''Back to the Top''' ]]&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;br /&gt;
&amp;lt;span id=&amp;quot;BackToTop&amp;quot;&amp;gt;&amp;lt;/span&amp;gt;&lt;br /&gt;
&amp;lt;div class=&amp;quot;noprint&amp;quot; style=&amp;quot;background-color:#fc3; color:#d33; position:fixed; bottom:2%; right:0.25%; padding:0; margin:0;&amp;quot;&amp;gt;&lt;br /&gt;
[[#top| '''Back to the Top''' ]]&lt;br /&gt;
&amp;lt;/div&amp;gt;&lt;/div&gt;</summary>
		<author><name>Sharon</name></author>
		
	</entry>
</feed>